Combining immunotherapy with bacterial injection shows promise in treatment-refractory solid tumors
Combining immunotherapy with bacterial injection shows promise in treatment-refractory solid tumors
Related Articles
Cancerwise Podcast
MD Anderson’s Cancerwise podcast features insights from our experts on cancer diagnosis and treatment, research breakthroughs, and prevention, as well as stories from survivors and…
A Phase Ib study of Rezatapopt in combination with Azacitidine in patients with Relapsed/Refractory TP53 Y220C mutant myeloid malignancies (Acute Myeloid Leukemia or Myelodysplastic syndrome)
A non-randomized phase Ib study of PC14586 (PMV therapeutics) in patients diagnosed with TP53Y220C-mutant myeloid malignancies, including AML and MDS.
Study uncovers target to overcome resistance in ARID1A-mutant cancers
Study uncovers target to overcome resistance in ARID1A-mutant cancers
Tips for using AI to find cancer information
Artificial intelligence can be a quick way to filter large amounts of information. But is it a reliable source for health topics? MD Anderson’s Caroline…
American Society for Radiation Oncology announces 2025 fellows – The Cancer Letter
The American Society for Radiation Oncology selected 43 members to receive the ASTRO Fellow designation this year. Fellows are chosen for their achievements and contributions…
50 hospital and health system chief digital officers to know | 2025 – Becker’s Hospital Review | Healthcare News & Analysis
Becker’s is proud to recognize 50 chief digital officers who are driving digital transformation in hospitals and health systems nationwide in 2025. As digital efforts…
Novel agent restores p53 function in p53-mutated AML
Novel agent partially restores p53 function in p53-mutated AML
Cancer patients and the flu: What you should know
What do cancer patients need to know about the flu virus, and what should you do if you catch it? Find out from Roy Chemaly,…
Specific co-mutations in KRAS-mutant NSCLC improve treatment response
Specific co-mutations in KRAS-mutant NSCLC improve treatment response
MD Anderson announces 10th cohort of Andrew Sabin Family Fellows
The University of Texas MD Anderson Cancer Center today announced its 10th cohort of Andrew Sabin Family Fellows, comprised of 10 early career cancer researchers.…